Professional Documents
Culture Documents
Tommy Sunartomo
Anestesiology & Reanimation Departement
Medical Faculty of Airlangga University
RSUD Dr. Soetomo Surabaya
Preparation
Detailed
Primary Reevaluation
Secondary
Survey
Survey
Resuscitation Definitive
Adjuncts Reevaluation
Care
Adjuncts
Reevaluation
Primary Survey
Airway with C-Spine protection
Breathing / ventilation / oxigenation
Circulation : stop the bleeding
Disability / neurological status
Expose/ Environment / body temperature
Basic Principal Management
• Stop the bleeding
• Restore the volume
• The goals haemorrhage
− minimize :
− restore organ perfusion and tissue oxygenation
− prevent hypothermia, coagulopathy and acidosis
− optimize patient outcome
Interventions
Hemostatic Direct
resuscitation Pressure/
tourniquet
Hemostatic Agents
Estimate Blood Loss
Clinical Presentation
• Depend on Estimate Blood Loss
• Class I : < 15% EBV} Hemodynamic Stable
• Class II : 15 – 30% EBV
}
• Class III : 30 – 40% EBV
Hemodynamic Unstable
TRANSIENT RESPONSE
NO RESPONSE
Haemodynamic Stable
• Closed observation & monitoring
• Maintenance fluid
• Further diagnostic examination
• Endovascular intervention ?
• Correction of coagulopathy
• Haemostatic agents ?
Haemodynamic Unstable
• < C > ABC resuscitation
• Permissive hypotension
• Limitation of crystalloid
• Early use of blood and blood products
• Early use of TXA
• Surgical exploration-Surgical Resuscitation
Damage-Control Resuscitation
Vasospasme
Mengerutkan robekan
Menurunkan aliran darah
Agregasi trombosit
Sumbat lunak
20 mnt
Beb.
Cascade koagulasi
Hari s/d
Terbentuk fibrin
minggu
Sumbat lebih keras
24 jam
Fibrin yang lengkap Penyembuhan
Tahan terhadap tensi normal pembuluh darah
Pemberian Cairan Agresif
MAP Hemodilusi
Vasospasme hilang
Cascade Oksigenasi
koagulasi jaringan
terganggu
Trombus Vasospasme
rusak/hanyut
Perdarahan bertambah
Restrictive Fluid Administration
▪ Tranexamic acid:
▪ Prevent fibrinolysis
▪ Useful within 3 hours of injury
▪ Recombinant human factor VIIa:
▪ Does not decrease mortality
▪ thrombo-embolic complications
▪ Prothrombin complex, which contains factors II, VII, IX,
X, C,and S:
▪ mortality, transfusion requirements,
complications, & lengths of stay
Hemostatic Adjuncts
▪ Anti-fibrinolytic agents
▪ Early administration of tranexamic acid (TXA), an anti-
fibrinolytic agent, (slightly decrease the risk of death from
bleeding)
▪ Factor-concentrates
▪ recombinant factor VIIa or prothrombin complex
concentrates (PCCs) (lack of evidence)
Resuscitation Goals and Monitoring
Acidosis
Hypothermia
Massive RBC
transfusion
Prevent Hypothermia
GOAL:
Pre Hospital Care
Get the patient to the trauma Less than 20 minutes
center
Resuscitation
Abbreviated surgical
GOAL: Procedure
Reverse hypothermia
Reverse coagulopathy
Reverse acidosis
Hemodynamics support
Remove packing
Definitive Surgical Repair
Serial primary abdominal
closure
Diuresis
GOAL:
Permissive hypotension, To titrate and control the blood Dutton et al. 2002
Hypotensive pressure less than normal range Morrison et al 2011
resuscitation
To limit the volume of fluid to be Brown et al 2013
Restricted resuscitation, administered Schreiber et al. 2015
Controlled resuscitation
To restrict the fluid resuscitation Bickel et al. 2013
Delayed resuscitation until admission to the hospital Sampalis et al. 1997
(Early resuscitation is opposite term Turner et al. 2000
that means to initiate fluid
resuscitation from pre-hospital
setting)
TRANSFUSI MASIF
Capital Health
TRAUMA ASSOCIATED SEVERE
HEMORRHAGE